Oncolys BioPharma Inc.

TSE:4588.T

556 (JPY) • At close September 18, 2024
Bedrijfsnaam Oncolys BioPharma Inc.
Symbool 4588.T
Munteenheid JPY
Prijs 557
Beurswaarde 12,965,057,288
Dividendpercentage 0%
52-weken bereik 420 - 798
Industrie Biotechnology
Sector Healthcare
CEO Mr. Yasuo Urata M.Sc.
Website https://www.oncolys.com

An error occurred while fetching data.

Over Oncolys BioPharma Inc.

Oncolys BioPharma Inc. engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States. Its product pipeline includes Telomelysin (OBP-301), an oncolytic adenovirus that is in phase II clinical trial for

Vergelijkbare Aandelen

Ohki Healthcare Holdings Co.,Ltd. logo

Ohki Healthcare Holdings Co.,Ltd.

3417.T

925 JPY

Precision System Science Co., Ltd. logo

Precision System Science Co., Ltd.

7707.T

267 JPY

Wakamoto Pharmaceutical Co.,Ltd. logo

Wakamoto Pharmaceutical Co.,Ltd.

4512.T

243 JPY

DVx Inc. logo

DVx Inc.

3079.T

915 JPY

Create Medic Co., Ltd. logo

Create Medic Co., Ltd.

5187.T

956 JPY

OLBA HEALTHCARE HOLDINGS, Inc. logo

OLBA HEALTHCARE HOLDINGS, Inc.

2689.T

1,896 JPY

Satudora Holdings Co.,Ltd. logo

Satudora Holdings Co.,Ltd.

3544.T

823 JPY

Advantage Risk Management Co., Ltd. logo

Advantage Risk Management Co., Ltd.

8769.T

559 JPY

Carna Biosciences, Inc. logo

Carna Biosciences, Inc.

4572.T

396 JPY

Japan Hospice Holdings Inc. logo

Japan Hospice Holdings Inc.

7061.T

1,421 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)